A Randomized Parallel Controlled Phase II Trial of Recombinant Human Endostatin Added to Neoadjuvant Chemotherapy for Stage III Breast Cancer
Year: 2020
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Clinical Breast Cancer
Authors: Xiangmei Zhang, Zhenzhen Zhang, Miao Cao, Beichen Liu, Motomi Mori, Shiuh-Wen Luoh, Raymond Bergan, Yueping Liu, Yunjiang Liu
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W3021800368
